Four (4) each Genomic Sequencing Systems

The FDA is seeking to acquire four genomic sequencing systems to support its Human Foods Program. The systems must be brand name or equal to Illumina MiSeq i100 Plus and Illumina DRAGENTM Bio-IT Platform. The acquisition aims to replace aging sequencers and enable high-throughput, cost-effective, and rapid sequencing for food safety surveillance, regulatory compliance, and novel genomic applications. The contractor will be responsible for providing hands-on training for FDA staff and performing preventative maintenance visits. Key aspects of the job include: • Providing four genomic sequencing systems • Replacing aging sequencers • Enabling high-throughput sequencing for food safety surveillance • Providing hands-on training for FDA staff • Performing preventative maintenance visits